Malignant Pleural Mesothelioma - Alfacell Forms New Thoracic Cancer Advisory Board

Alfacell Forms New Thoracic Cancer Advisory Board
[Press Release] PR Newswire via Yahoo! Finance - Jan 27 6:32 AM
Alfacell Corporation today announced the formation of a Thoracic Cancer Advisory Board to support the Company's strategic focus on developing novel ribonuclease therapies for the treatment of diseases such as mesothelioma and non-small cell lung cancer .Save to My Web

Lilly Reports Q4 EPS of $.64, or $.80 Excluding Charges; 2005 EPS of $1.81, or $2.87 Excluding Charges
FinanzNachrichten - Jan 26 3:39 AM
INDIANAPOLIS, Jan. 26 /PRNewswire-FirstCall/ -- Eli Lilly ( Nachrichten / Aktienkurs ) and Company today announced financial results for the fourth quarter and full year of 2005.Save to My Web

Malignant Pleural Mesothelioma - Lung scars rarely lead to asbestos-related diseases, U.K. appeals court says

Lung scars rarely lead to asbestos-related diseases, U.K. appeals court says
Business Insurance - Jan 29 10:07 AM
LONDONOverturning a legal precedent of more than 20 years, the U.K. Court of Appeal last week ruled that anxiety induced by the asbestos-related condition pleural plaques should not be compensable.Save to My Web

Malignant Pleural Mesothelioma - Lilly Reports Q4 EPS of $.64, or $.80 Excluding Charges; 2005 EPS of $1.81, or $2.87 Excluding Charges

Lilly Reports Q4 EPS of $.64, or $.80 Excluding Charges; 2005 EPS of $1.81, or $2.87 Excluding Charges
FinanzNachrichten - Jan 26 3:39 AM
INDIANAPOLIS, Jan. 26 /PRNewswire-FirstCall/ -- Eli Lilly ( Nachrichten / Aktienkurs ) and Company today announced financial results for the fourth quarter and full year of 2005.Save to My Web

Alfacell Forms New Thoracic Cancer Advisory Board
RedNova - Jan 27 7:31 AM
BLOOMFIELD, N.J., Jan. 27 /PRNewswire-FirstCalSave to My Web

Alfacell Forms New Thoracic Cancer Advisory Board
[Press Release] PR Newswire via Yahoo! Finance - Jan 27 6:32 AM
Alfacell Corporation today announced the formation of a Thoracic Cancer Advisory Board to support the Company's strategic focus on developing novel ribonuclease therapies for the treatment of diseases such as mesothelioma and non-small cell lung cancer .Save to My Web

Malignant Pleural Mesothelioma - Lilly Reports Q4 EPS of $.64, or $.80 Excluding Charges; 2005 EPS ...

Lilly Reports Q4 EPS of $.64, or $.80 Excluding Charges; 2005 EPS ...
PharmaLive.com (press release), PA - Jan 26, 2006... For the fourth quarter of 2005, Alimta, a treatment for malignant pleural mesothelioma and second-line treatment of non-small-cell lung cancer, generated sales ...

Interferon Alpha May Help Treat Malignant Pleural Mesothelioma ...
DG News - Feb 3, 2006... maintenance therapy may provide substantial improvement in survival over existing therapies in patients with malignant pleural mesothelioma (MPM), according to ...

Lilly Reports Q4 EPS of $.64, or $.80 Excluding Charges; 2005 EPS ...
PR Newswire (press release), NY - Jan 26, 2006... Alimta For the fourth quarter of 2005, Alimta, a treatment for malignant pleural mesothelioma and second-line treatment of non-small-cell lung cancer ...

Malignant Pleural Mesothelioma - Asbestos: the iron grip of latency

Asbestos: the iron grip of latency
News-Medical.net, Australia - Jan 10, 2006... of the lung, or in its pleural lining, and ... and larynx, including mesotheliomas, the most malignant of the ... the number of fatalities from mesothelioma or other ...

Alfacell Forms New Thoracic Cancer Advisory Board
Yahoo! News (press release) - Jan 27, 2006... He has studied pleural mesothelioma since 1988 when he ... treatment and management of mesothelioma and lung ... registration study for malignant mesothelioma (MM) and ...

Malignant Pleural Mesothelioma - Mesothelioma Treatment 101

Mesothelioma Treatment 101
Only Idol, MS - Jan 26, 2006... In February 2004, the Food and Drug Administration approved pemetrexed (brand name Alimta) for treatment of malignant pleural mesothelioma. ...

Alfacell Forms New Thoracic Cancer Advisory Board
Yahoo! News (press release) - Jan 27, 2006... He has studied pleural mesothelioma since 1988 when he ... treatment and management of mesothelioma and lung ... registration study for malignant mesothelioma (MM) and ...

Lilly Reports Q4 EPS of $.64, or $.80 Excluding Charges; 2005 EPS ...
PharmaLive.com (press release), PA - Jan 26, 2006... For the fourth quarter of 2005, Alimta, a treatment for malignant pleural mesothelioma and second-line treatment of non-small-cell lung cancer, generated sales ...